Australian Securities and Investments Commission v Holista Colltech Ltd

Link copied
Case Copied 66 min read

FEDERAL COURT OF AUSTRALIA

Australian Securities and Investments Commission v Holista Colltech Ltd [2024] FCA 244  

File number: WAD 177 of 2021
Judgment of: SARAH C DERRINGTON J
Date of judgment: 19 March 2024
Catchwords:

CORPORATIONS – alleged contraventions of ss 674(2) and 1041H(1) of the Corporations Act 2001 (Cth) – where company failed to notify the Australian Securities Exchange of certain information in breach of continuous disclosure obligations – where company engaged in conduct, in relation to a financial product or a financial service, that was misleading or deceptive, or likely to mislead or deceive – whether company knew if non-disclosed information would, if generally available, have a material effect on the price or value of the company shares – application for declaratory relief under s 1317E of the Corporations Act or s 21 of the Federal Court of Australia Act 1976 (Cth) – determination of appropriate penalty under s 1317G of the Corporations Act

DIRECTORS’ DUTIES – alleged contraventions of ss 180(1), and 1309(2) or 1309(12) of the Corporations Act – whether director made available or gave, or alternatively authorised or permitted the making available or giving of, information related to the affairs of the company and that was false or misleading in a material particular – attribution of knowledge or recklessness of director to conduct of the company – disqualification order under s 206C(1) of the Corporations Act – determination of appropriate penalty under s 1317G of the Corporations Act

Legislation:

Australian Securities and Investments Commission Act 2001 (Cth) ss 1(2)(b), 1(2)(g), 12GBA

Crimes Act 1958 (Cth) s 4AA

Criminal Code Act 1995 (Cth) Sch Criminal Code ss 5.2, 5.3, 5.4

Corporations Act 2001 (Cth) ss 9, 92,111AD(1), 111AK, 180(1), 206C(1), 674(2), 674A, 675, 675A, 676, 677, 727, 728, 761A, 764A, 1041H(1), 1211B, 1309(2)/(12), 1311(1), 1317E, 1317F, 1317G(1)

Evidence Act 1995 (Cth) s 191

Fair Work Act 2009 (Cth) s 546

Federal Court of Australia Act 1976 (Cth) s 21

Strengthening Corporate and Financial Sector Penalties Act 2019 (Cth)

Treasury Laws Amendment (2021 Measures No.1) Act 2021 (Cth) ss 674, 675, 674A, 675A

Corporations (Coronavirus Economic Response) Determination (No. 2) 2020 (Cth ss 5, 8)

Cases cited:

Australian Building and Construction Commissioner v Construction, Forestry, Mining and Energy Union (2017) 254 FCR 68

Australian Building and Construction Commissioner v Pattinson [2022] HCA 13; 274 CLR 450

Australian Competition and Consumer Commission v Reckitt Benickser (Australia) Pty Ltd [2016] FCAFC 181; 340 ALR 25

Australian Competition and Consumer Commission v High Adventure Pty Ltd [2005] FCAFC 247; ATPR 42-091

Australian Competition and Consumer Commission v Leahy Petroleum (No 2) [2005] FCA 254; 215 ALR 281

Australian Ophthalmic Supplies Pty Ltd v McAlary-Smith (2008) 165 FCR 560

Australian Securities and Investments Commission v Australia and New Zealand Banking Group Limited [2023] FCA 256

Australian Securities and Investments Commission v GetSwift Ltd (Penalty Hearing) [2023] FCA 100

Australian Securities and Investments Commission v Wilson (No 3) [2023] FCA 1009

Australian Securities and Investments Commission v Rio…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Australian Securities and Investments Commission v Holista C... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2024] FCA 244
Decision Date

CaseChat Overview and Summary

The Australian Securities and Investments Commission (ASIC) brought proceedings against Holista Colltech Ltd and one of its directors, Dr Marnickavasagar, for alleged contraventions of various sections of the Corporations Act 2001 (Cth). The primary issues were whether Holista failed to notify the Australian Securities Exchange (ASX) of certain information, which was in breach of continuous disclosure obligations, and whether Holista and Dr Marnickavasagar engaged in conduct that was misleading or deceptive. Additionally, the court had to determine whether Dr Marnickavasagar knew that the non-disclosed information would have a material effect on the price or value of the company shares, and if so, whether he made or authorised misleading information about the company. The case also involved determining appropriate penalties under the relevant sections of the Corporations Act.

The court found that Holista had contravened s 674(2) and s 1041H of the Corporations Act, as it failed to notify the ASX of material information regarding the distribution rights of a product. Dr Marnickavasagar was found to have contravened ss 180(1), 1309(2) and 1309(12) of the Corporations Act, as he authorised misleading information about the company's affairs. The court held that the declaration of contravention was mandatory under s 1317E of the Corporations Act for s 674(2), and appropriate under s 21 of the Federal Court of Australia Act 1976 (Cth) for s 1041H. The court concluded that the agreed penalties were appropriate given the breaches.

The court made several orders, including a pecuniary penalty of $1,800,000 for Holista and $150,000 for Dr Marnickavasagar. Dr Marnickavasagar was also disqualified from managing a corporation for four years. Holista and Dr Marnickavasagar were ordered to pay the plaintiff's costs, and Holista was required to submit whether the penalty should be paid in instalments. The orders were to be entered forthwith.

Orders

Orders of the court

1. Pursuant to s 1317G(1) of the Corporations Act, the first defendant pay to the Commonwealth of Australia a pecuniary penalty in the amount of $1,800,000 in respect of the contraventions of ss 674(2) and 1041H of the Corporations Act.

2. Pursuant to s 1317G(1) of the Corporations Act, within 28 days of service of this Order, the second defendant pay to the Commonwealth a pecuniary penalty in the

amount of $150,000 in respect of the contraventions of ss 180(1), 1309(2) and (12) of the Corporations Act.

3. Pursuant to s 206C(1) of the Corporations Act, the second defendant be disqualified from managing a corporation for a period of 4 years, from the date of this Order.

4. Within 28 days of service of this Order, the second defendant pay the plaintiff’s costs of the proceedings, fixed in the amount of $200,000.

5. The first defendant pay the plaintiff’s costs of the proceedings in so far as they exceed $200,000 to be taxed, if not agreed.

6. Within 14 days of service of this Order, the first defendant and the plaintiff file and serve written submissions, not exceeding three pages in length, as to whether the pecuniary penalty ordered to be paid by the first defendant should be paid in instalments.

7. The Orders 1 to 6 are taken to be entered forthwith.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

As concerns Dr Marnickavasagar, the parties are agreed as to the appropriate penalty. As to liability, two matters remain in dispute, although they are said not to change the appropriateness of the agreed penalty. The first concerns Dr Marnickavasagar’s attempt to rely on the existence of a pre-existing distribution agreement and the provisions of a “sales projection” spreadsheet to diminish his culpability; the second, his alleged state of mind at the relevant time.THE SUMMARY OF AGREED FACTS AND ADMISSIONS As I have already mentioned, the parties filed a SAFA on 27 November 2023. The matters as I have framed them below are summarised from that document. Dr Marnickavasagar was, at all relevant times, an “officer” of Holista within the meaning of s 9 of the Corporations Act. I observe that, in some of the relevant documents, Dr Marnickavasagar is referred to by shortened versions of his name, “Dr Rajen” or “Dr Manicka”. At all relevant times, ordinary shares in Holista were “securities” within the meaning of: ss 92 and 761A of the Corporations Act; “ED securities” within the meaning of ss 111AD(1) and 111AK of the Corporations Act; and “financial products” as a consequence of s 764A(1)(a) of the Corporations Act. Between 9 April 2020 and 9 July 2020 (the Relevant Period), Holista marketed a natural non-alcoholic sanitiser product under the brand name, “NatShield”, which utilised an active ingredient known as “Path-Away”. Path-Away is a proprietary formula owned or otherwise held by Global Infection Control Consultants LLC (GICC). At least between 15 and 20 February 2020, Dr Marnickavasagar on behalf of Holista, and Dr Arthur Martin on behalf of GICC, engaged in discussions concerning Holista’s Path-Away distribution rights, product development, and other ancillary matters. As a result, a draft Binding Collaboration Term Sheet (BCTS) was prepared. On 20 February 2020 at 5.08 pm AEDT, Holista provided the ASX with, and published on the Market Announcement Platform (MAP) an announcement (20 February 2020 Announcement) which stated, inter alia:…(e)GICC LLC has agreed to grant Holista marketing and distribution rights of Path-Away® beyond ASEAN region to include UK and Europe. Holista will distribute NatShield™ Sanitiser and the nasal sanitising balm into the UK and Europe. Holista will also work collaboratively with GICC LLC in the North American market to market NatShield™ Sanitiser and the nasal sanitiser balm;(f)“We are also grateful to Dr Martin and GICC LLC for granting Holista the distribution rights for Path-Away® to include the UK and Europe. We are excited to collaborate Dr Martin’s team in the North American market on the NatShield™ Sanitiser,” [Dr Marnickavasagar] added. In fact, as at the date of the 20 February 2020 Announcement, the BCTS had been executed by Holista, but not by GICC or its representatives. The BCTS was subsequently executed by Dr Martin on behalf of GICC on 13 April 2020, following an urgent email request from Dr Marnickavasagar that he do so, after an ASX Aware Query was issued to Holista on 9 April 2020. The BCTS included the words “[a]greed to and accepted this 20th day of February, 2020” above the execution block.

Evidence

Evidence Before The Court

Section 1317F provides:1317F Declaration of contravention is conclusive evidence A declaration of contravention is conclusive evidence of the matters referred to in subsection 1317E(2). Consequently, if I am satisfied that Holista has contravened s 674(2), it being a civil penalty provision, I must make a declaration in the terms prescribed by s 1317E(1). As was observed by the Full Court in Mayfair Wealth Partners Pty Ltd v Australian Securities and Investments Commission [2022] FCAFC 170 at [184] (per Jagot, O’Bryan and Cheeseman JJ) in respect of the analogous s 12GBA of the Australian Securities and Investments Commission Act 2001 (Cth) (ASIC Act), the mandatory terms of the section necessarily override the discretionary considerations to which a court might otherwise have given weight, in declining to make a declaration. Section 1317E(1) is not, however, relevant to the declaration sought in respect of the contravention of s 1041H, it not being a civil penalty provision. Hence ASIC’s reliance on s 21 of the FCA Act, which confers power on the Court to make binding declarations of right in civil proceedings in which it has original jurisdiction. On the basis of the SAFA and the joint written submissions, I am satisfied that Holista has contravened ss 674(2) and 1041H of the Corporations Act. Accordingly, I am required by s 1317E(1) to make a declaration of contravention in respect of s 674(2). It is also appropriate that I exercise the power conferred by s 21 of the FCA Act to make a declaration of contravention in respect of s 1041H. While the discretion conferred by s 21 of the FCA Act is broad, it should only be exercised where the question is real and not theoretical, the person raising it has a real interest to raise it, and there is a proper contradictor, being someone who has a true interest to oppose the declaration: Forster v Jododex Australia Pty Ltd (1972) 127 CLR 421,437-438, quoting Lord Dunedin in Russian Commercial and Industrial Bank v British Bank for Foreign Trade Ltd [1921] 2 AC 437, 448. As has been observed on several occasions, the fact that the parties have agreed that a declaration of contravention should be made does not relieve the Court of the obligation to satisfy itself that the making of the declaration is appropriate: Commonwealth v Director, Fair Work Building Industry Inspectorate [2015] HCA 46; 258 CLR 482 at [48] and [59]; NW Frozen Foods[1996] FCA 1134; 71 FCR 285 at 290-291; Minister for Industry, Tourism & Resources v Mobil Oil (2004) ATPR 41-993 at 48, 626. It is not the role of the Court to simply “rubber stamp” orders agreed between a regulator and a person who has admitted a statutory contravention: Re Chemeq Ltd; Australian Securities and Investments Commission v Chemeq Ltd [2006] FCA 936; 234 ALR 511 at [100]; Construction, Forestry, Mining and Energy Union v De Martin & Gasparini Pty Ltd (No 3) [2018] FCA 1395 at [74]; Australian Securities and Investments Commission v Australia and New Zealand Banking Group Limited [2023] FCA 256 at [50] (ASIC v ANZ).

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established

Section 1317E is a mandatory provision. It provides, relevantly:1317E Declaration of contravention of a civil penalty provisionDeclaration of contravention(1) If a Court is satisfied that a person has contravened a civil penalty provision, the Court must make a declaration of contravention.(2) The declaration must specify the following:(a) the Court that made the declaration;(b) the civil penalty provision that was contravened;(c)the person who contravened the provision;(d) the conduct that constituted the contravention;(e)if the contravention is of a corporation/scheme civil penalty provision—the corporation, registered scheme or notified foreign passport fund to which the conduct related;(f)if the contravention is of subsection 1211B(1) or (2) (complying with the Passport Rules for this jurisdiction) —the passport fund in relation to which the obligation was imposed on the person;(g)if the contravention is of subsection 670A(4), 727(6), 728(4) or 1309(12) (misleading statements etc.)—the corporation, registered scheme or notified foreign passport fund to which the conduct related. Section 1317F provides:1317F Declaration of contravention is conclusive evidence A declaration of contravention is conclusive evidence of the matters referred to in subsection 1317E(2). Consequently, if I am satisfied that Holista has contravened s 674(2), it being a civil penalty provision, I must make a declaration in the terms prescribed by s 1317E(1). As was observed by the Full Court in Mayfair Wealth Partners Pty Ltd v Australian Securities and Investments Commission [2022] FCAFC 170 at [184] (per Jagot, O’Bryan and Cheeseman JJ) in respect of the analogous s 12GBA of the Australian Securities and Investments Commission Act 2001 (Cth) (ASIC Act), the mandatory terms of the section necessarily override the discretionary considerations to which a court might otherwise have given weight, in declining to make a declaration. Section 1317E(1) is not, however, relevant to the declaration sought in respect of the contravention of s 1041H, it not being a civil penalty provision. Hence ASIC’s reliance on s 21 of the FCA Act, which confers power on the Court to make binding declarations of right in civil proceedings in which it has original jurisdiction. On the basis of the SAFA and the joint written submissions, I am satisfied that Holista has contravened ss 674(2) and 1041H of the Corporations Act. Accordingly, I am required by s 1317E(1) to make a declaration of contravention in respect of s 674(2). It is also appropriate that I exercise the power conferred by s 21 of the FCA Act to make a declaration of contravention in respect of s 1041H. While the discretion conferred by s 21 of the FCA Act is broad, it should only be exercised where the question is real and not theoretical, the person raising it has a real interest to raise it, and there is a proper contradictor, being someone who has a true interest to oppose the declaration: Forster v Jododex Australia Pty Ltd (1972) 127 CLR 421,437-438, quoting Lord Dunedin in Russian Commercial and Industrial Bank v British Bank for Foreign Trade Ltd [1921] 2 AC 437, 448.